Research Updates

Back to project

Hereditary Hemorrhagic Telangiectasia (Osler-Weber-Rendu syndrome): update of October 19, 2026

What's new and why it matters

  1. A study found that hereditary hemorrhagic telangiectasia (HHT) is often overlooked in young women with heavy menstrual bleeding, particularly if there’s a family history. This highlights the importance of considering HHT in these cases. Based on: 1
  2. A case report showed that low energy long pulse laser treatment improved vascular problems in a woman with HHT, with no side effects reported. This suggests a potential effective treatment option for some patients. Based on: 2

Materials in this update

  1. Integrating Hereditary Hemorrhagic Telangiectasia into the Diagnostic Workup of Adolescent Heavy Menstrual Bleeding.
    PubMed

    Oct 14, 2026

    A study found that hereditary hemorrhagic telangiectasia (HHT) is often missed as a cause of heavy menstrual bleeding in young women, especially if there’s a family history.

  2. OCT Monitoring of Low Energy Long Pulse 1064 nm Nd:YAG Laser Treatment of a Hereditary Hemorrhagic Telangiectasia-Associated Vascular Anomaly.
    PubMed

    Oct 13, 2026

    A case report showed that low energy long pulse laser treatment effectively improved vascular issues in a woman with hereditary hemorrhagic telangiectasia, with no side effects noted.

All updates for Hereditary Hemorrhagic Telangiectasia (Osler-Weber-Rendu syndrome)
Email language